2'-deoxy-2'-fluoro-2'-C-methylcytidine,
2'-F-2'-C-MeC,
4-amino-(3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one,
PSI 6130,
PSI-6130,
PSI6130,
PSI-6130,
817204-33-4,
2'-deoxy-2'-fluoro-2'-C-methylcytidine,
4-Amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one,
PSI 6130,
Cytidine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-,
PSI6130,
UNII-05J68784G1,
R-1656,
05J68784G1,
A1-01395,
4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-2-yl]pyrimidin-2-one,
R 1656,
SCHEMBL379121,
AC1O5B17,
CHEMBL223482,
2'-Fluoro-2'-C-methylcytidine,
DTXSID10231287,
NYPIRLYMDJMKGW-VPCXQMTMSA-N,
4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one,
AMX10216,
BCP09351,
MFCD13176566,
RO5855,
ZINC34082873,
2-deoxy-2-fluoro-2-C-methylcytidine,
AKOS016009199,
API0014097,
CM14183,
CS-0597,
SB12050,
AJ-86848,
AK109452,
HY-10165,
SC-50499,
R 1656; PSI 6130,
AX8229275,
ST24043181,
cas:817204-33-4;PSI-6130,
Cytidine, 2'-C-methyl-2'-Fluoro-2'-deoxy-,
(2'R)-2'-deoxy-2'-fluoro-2'-methylcytidine,
A11519,
W-5552,
2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-2-methyl-.beta.-D-ribofuranosyl)-,
D00RFZ,
PSI-6130-DP,
PSI-6130-MP,
PSI-6130-TP,
2'-F-2'-C-MeC,
AIDS336151,
ACN-029007,
CID6481236,
PS-6130,
Hepatitis C virus therapy, Pharmasset/Roche,
A3737,
RO-4995855,
2/'-Deoxy-2/'-fluoro-2/'-C-methylcytidine,
R-1479,
C504520,
4-amino-(3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one,
478182-28-4,